Your browser doesn't support javascript.
loading
PALB2 variant status in hematological malignancies - a potential therapeutic target?
Oldreive, Ceri E; Byrd, Philip J; Stewart, Grant S; Taylor, Alexander J; Farhat, Sana; Skowronska, Anna; Smith, Edward; Raghavan, Manoj; Janic, Dragana; Dokmanovic, Lidija; Clokie, Sam; Davies, Nicholas; Kwok, Marwan; Pratt, Guy; Paneesha, Shankara; Moss, Paul; Stankovic, Tatjana; Taylor, Malcolm.
Afiliación
  • Oldreive CE; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Byrd PJ; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Stewart GS; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Taylor AJ; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Farhat S; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Skowronska A; b West Midlands Regional Genetics Laboratory , Birmingham , UK.
  • Smith E; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Raghavan M; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Janic D; c School of Medicine, University Children's Hospital , University of Belgrade , Belgrade , Serbia.
  • Dokmanovic L; c School of Medicine, University Children's Hospital , University of Belgrade , Belgrade , Serbia.
  • Clokie S; b West Midlands Regional Genetics Laboratory , Birmingham , UK.
  • Davies N; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Kwok M; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Pratt G; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Paneesha S; d Heartlands Hospital , Birmingham , UK.
  • Moss P; e Institute of Immunity and Infection, University of Birmingham , Birmingham , UK.
  • Stankovic T; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
  • Taylor M; a Institute of Cancer and Genomic Sciences, University of Birmingham , Birmingham , UK.
Leuk Lymphoma ; 60(7): 1823-1826, 2019 07.
Article en En | MEDLINE | ID: mdl-30614742
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Biomarcadores de Tumor / Neoplasias Hematológicas / Proteína del Grupo de Complementación N de la Anemia de Fanconi Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Variación Genética / Biomarcadores de Tumor / Neoplasias Hematológicas / Proteína del Grupo de Complementación N de la Anemia de Fanconi Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: Leuk Lymphoma Asunto de la revista: HEMATOLOGIA / NEOPLASIAS Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido